| By PR Newswire | Article Rating: |
|
| August 5, 2008 01:33 PM EDT | Reads: |
622 |
APS Owner and President
TriMix gel(TM) is a gel-based treatment which has been prescribed for ED patients who have failed on Viagra(R), Levitra(R) and Cialis(R) type tablets or who could not tolerate the side effects. It uses an all-in-one ED gel(TM) Application System (pat. pend.) which stores, mixes and applies the medicine at time of use. One feature of this methodology of medicine delivery is that the medicine in this form does not have to be refrigerated and can be carried by the patient at room temperature. Additionally, TriMix gel(TM) uses FDA approved vasodilation components but does not have to be self injected with a needle because it is classified as a topical gel.
TriMix gel contains active ingredients which are classified as medicine and are listed in the US Pharmacopeia. Therefore, a patient would need a prescription from his physician to obtain TriMix gel. For an order form for your doctor, visit http://www.trimixgel.com and click the prescription form. Give the form to your doctor. He can fax a prescription to American Pharmacy Solutions at 877-387-4649 and the pharmacy will ship the medicine directly to the patient.
Recently, clinical trials were performed on TriMix gel(TM). All the test patients were men who had failed on Viagra(R), Levitra(R) or Cialis(R). These patients were given TriMix gel(TM). All the test patients received some degree of positive effect from TriMix gel(TM). It was determined that 40% of the test patients achieved a result sufficient for sexual intercourse over Viagra(R), Levitra(R) or Cialis(R) tablets. For more information visit the web at http://trimixgel.com/studies.html .
The profession of pharmacy has always been based on the patient-physician-pharmacist relationship, known as the "Triad." Through this "Triad" relationship, patient needs are determined by a physician, who chooses a treatment regimen that may include a compounded medication. Physicians often prescribe compounded medications for various reasons, such as when a patient cannot ingest a medication in its available form. A pharmacist can prepare the medication in cream, liquid, gel or any other form that the patient can more easily take.
TriMix Laboratories LLC is a medical research and marketing firm specializing in the urological subspecialty of erectile dysfunction. American Pharmacy Solutions is a recognized leader in pharmaceutical compounding, helping Physicians and Veterinarians with medicine precisely customized for each individual patient. American Pharmacy maintains federal and state licenses and permits and is registered to dispense in almost all states. For more information, visit http://www.TriMix-gel.com .
This press release contains forward-looking statements. These statements involve risks and uncertainties which may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed and actual results may differ materially. Ingredients in TriMix gel(TM) are FDA approved but TriMix gel(TM) is a custom compound made in a pharmacy and therefore has not been approved by the FDA for treatment of ED. TriMix gel(TM) requires a valid prescription from a physician. You should discuss the risks and side effects associated with this drug with your physician. Before taking any action, consult your physician.
Contact:
T.J. Harkins
TriMix Laboratories
Cherry Hill, NJ
856-428-7008
SOURCE TriMix Laboratories LLC
Published August 5, 2008 Reads 622
Copyright © 2008 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
- Microsoft Tries Hadoop on Azure
- OpenXava 4.3: Rapid Java Web Development
- Asynchronous Logging Using Spring
- StorSimple Supports OpenStack
- What to Expect in 2012: Cloud Computing and Open Source Software
- Will PaaS Finally Bring Open Source Love to the Enterprise?
- AT&T Joins OpenStack, Floats Cloud Architect
- Linux Virtualization and Tired Open Source Myths
- Red Hat Sets Up GlusterFS Advisory Board
- OpenOffice.com Lives
- Selecting a Business Intelligence Solution
- Cloud Computing: A Platform-First Approach
- Adobe Sends Flex to the Apache Foundation
- i-Technology in 2012: Five Industry Predictions
- Microsoft Tries Hadoop on Azure
- OpenXava 4.3: Rapid Java Web Development
- Asynchronous Logging Using Spring
- StorSimple Supports OpenStack
- What to Expect in 2012: Cloud Computing and Open Source Software
- Will PaaS Finally Bring Open Source Love to the Enterprise?
- AT&T Joins OpenStack, Floats Cloud Architect
- More Use Cases for Big Data Analytics
- Linux Virtualization and Tired Open Source Myths
- Red Hat Sets Up GlusterFS Advisory Board
- After Ubuntu, Windows Looks Increasingly Bad, Increasingly Archaic, Increasingly Unfriendly
- SCO CEO Posts Open Letter to the Open Source Community
- Simula Labs Launches Hosted Delivery Platform To Enable Enterprise Open Source Adoption
- Where Are RIA Technologies Headed in 2008?
- Source Claims SCO Will Sue Google
- How Open Is "Open"? – Industry Luminaries Join the Debate
- Latest SCO News is Plain Weird
- SCO Claims Linux Lifted ELF
- IBM Tells SCO Court It Can't Find AIX-on-Power Code
- Flashback: Investing in 'Professional Open Source' - Exclusive 2004 Interview with David Skok, Matrix Partners
- Developing an Application Using the Eclipse BIRT Report Engine API
- HP Starts Pushing Desktop Linux



















